Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
University of South Florida
mi
from
Tampa, FL
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Emory Universty
mi
from
Decatur, GA
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Emory Universty
mi
from
Decatur, GA
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Riley Children's Hospital
mi
from
Indianapolis, IN
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
University of Kentucky
mi
from
Lexington, KY
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Children's Hospital Boston
mi
from
Boston, MA
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Wayne State University
mi
from
Detroit, MI
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Cooper Health Systems
mi
from
Camden, NJ
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Cooper Health Systems
mi
from
Camden, NJ
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Atlantic Health System Morristown Medical Center
mi
from
Morristown, NJ
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Atlantic Health System Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Albany Medical Center
mi
from
Albany, NY
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
University of Rochester
mi
from
Rochester, NY
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
University of Oklahoma
mi
from
Oklahoma City, OK
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
University of Texas- Houston Medical School
mi
from
Houston, TX
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated:  12/22/2017
Washington University Center for Applied Research Sciences
mi
from
Saint Louis, MO
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)
Status: Enrolling
Updated: 12/22/2017
Washington University Center for Applied Research Sciences
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia
Status: Enrolling
Updated:  12/27/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia
Status: Enrolling
Updated: 12/27/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
Status: Enrolling
Updated:  12/27/2017
Stanford University School of Medicine, Department of Anesthesia
mi
from
Stanford, CA
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
Status: Enrolling
Updated: 12/27/2017
Stanford University School of Medicine, Department of Anesthesia
mi
from
Stanford, CA
Click here to add this to my saved trials
Effect of Intranasal Insulin on LH Concentrations in Man
Effect of Intranasal Insulin on LH Concentrations in Man
Status: Enrolling
Updated:  12/27/2017
TTTUHSC-Permian Basin
mi
from
Odessa, TX
Effect of Intranasal Insulin on LH Concentrations in Man
Effect of Intranasal Insulin on LH Concentrations in Man
Status: Enrolling
Updated: 12/27/2017
TTTUHSC-Permian Basin
mi
from
Odessa, TX
Click here to add this to my saved trials
Barley and Rice Mixture Effects on Blood Glucose
β-glucan Rich Barley and Rice Mixes and Post-prandial Glycemia - a Dose Response Study
Status: Enrolling
Updated:  12/28/2017
Arizona Biomedical Collaborative
mi
from
Phoenix, AZ
Barley and Rice Mixture Effects on Blood Glucose
β-glucan Rich Barley and Rice Mixes and Post-prandial Glycemia - a Dose Response Study
Status: Enrolling
Updated: 12/28/2017
Arizona Biomedical Collaborative
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
Evaluation of 3-V Bioscience-2640, a FASN Inhibitor, to Reduce de Novo Lipogenesis in Subjects With Characteristics of the Metabolic Syndrome
Status: Enrolling
Updated:  1/2/2018
University of Missouri
mi
from
Columbia, MO
Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
Evaluation of 3-V Bioscience-2640, a FASN Inhibitor, to Reduce de Novo Lipogenesis in Subjects With Characteristics of the Metabolic Syndrome
Status: Enrolling
Updated: 1/2/2018
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
Status: Enrolling
Updated:  1/2/2018
University of Missouri
mi
from
Columbia, MO
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
Status: Enrolling
Updated: 1/2/2018
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Groups, Multicenter Study to Investigate the Effects of Canagliflozin on Insulin Sensitivity, Hepatic Fat Content and Beta Cell Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
San Diego, La Jolla, CA
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Groups, Multicenter Study to Investigate the Effects of Canagliflozin on Insulin Sensitivity, Hepatic Fat Content and Beta Cell Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
San Diego, La Jolla, CA
Click here to add this to my saved trials
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Groups, Multicenter Study to Investigate the Effects of Canagliflozin on Insulin Sensitivity, Hepatic Fat Content and Beta Cell Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
mi
from
Gainesville, FL
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Groups, Multicenter Study to Investigate the Effects of Canagliflozin on Insulin Sensitivity, Hepatic Fat Content and Beta Cell Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Medical University of South Carolina
mi
from
Charleston, SC
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
City of Hope National Medical Center
mi
from
Duarte, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
UCLA Medical School
mi
from
Los Angeles, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
UCLA Medical School
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Kentucky
mi
from
Lexington, KY
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Massachusetts General Hospital
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Boston University School of Medicine
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Michigan
mi
from
Ann Arbor, MI
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Duke University
mi
from
Durham, NC
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Texas- Houston Medical School
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated:  1/4/2018
University of Calgary
mi
from
Calgary,
Scleroderma: Cyclophosphamide or Transplantation (SCOT)
A Randomized, Open-Label, Phase II Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation With Auto-CD34+HPC Versus Intravenous Pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis (SCSSc-01)
Status: Enrolling
Updated: 1/4/2018
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Tweens to Teens Project at Penn State
"Gender Development in Early Adolescence: Prenatal Hormones and Family Socialization"
Status: Enrolling
Updated:  1/4/2018
The Pennsylvania State University, Dept. of Psychology - Tweens to Teens Project
mi
from
University Park, PA
Tweens to Teens Project at Penn State
"Gender Development in Early Adolescence: Prenatal Hormones and Family Socialization"
Status: Enrolling
Updated: 1/4/2018
The Pennsylvania State University, Dept. of Psychology - Tweens to Teens Project
mi
from
University Park, PA
Click here to add this to my saved trials
Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
Optimal Hydrochlorothiazide Cessation in Diagnosis of Hyperparathyroidism
Status: Enrolling
Updated:  1/4/2018
University of Missouri
mi
from
Columbia, MO
Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
Optimal Hydrochlorothiazide Cessation in Diagnosis of Hyperparathyroidism
Status: Enrolling
Updated: 1/4/2018
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Status: Enrolling
Updated:  1/8/2018
Whole Family Health Center
mi
from
Vero Beach, FL
Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Status: Enrolling
Updated: 1/8/2018
Whole Family Health Center
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus
Glycemic Response of Bean-and-rice Meals in Persons With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  1/8/2018
Arizona State University, Nutrition Program
mi
from
Mesa, AZ
Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus
Glycemic Response of Bean-and-rice Meals in Persons With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 1/8/2018
Arizona State University, Nutrition Program
mi
from
Mesa, AZ
Click here to add this to my saved trials
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Allogeneic Hematopoietic Stem Cell Transplantation for Standard Risk Inherited Metabolic Disorders
Status: Enrolling
Updated:  1/9/2018
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Allogeneic Hematopoietic Stem Cell Transplantation for Standard Risk Inherited Metabolic Disorders
Status: Enrolling
Updated: 1/9/2018
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand
Evaluation of the Effect of Hypoglycemia on the Noradrenergic System With PET and a Highly Selective Norepinephrine Transporter Ligand
Status: Enrolling
Updated:  1/9/2018
PET Center, YCCI Hospital Research Unit (HRU)
mi
from
New Haven, CT
Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand
Evaluation of the Effect of Hypoglycemia on the Noradrenergic System With PET and a Highly Selective Norepinephrine Transporter Ligand
Status: Enrolling
Updated: 1/9/2018
PET Center, YCCI Hospital Research Unit (HRU)
mi
from
New Haven, CT
Click here to add this to my saved trials
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Status: Enrolling
Updated:  1/11/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
Status: Enrolling
Updated: 1/11/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Methuen, MA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Methuen, MA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Huntsville, AL
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Burbank, CA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials